CytoPherx Lands $5,000,000 New Funding

  • Feed Type
  • Date
    6/21/2010
  • Company Name
    CytoPherx
  • Mailing Address
    401 W. Morgan Rd. Ann Arbor, MI 48108
  • Company Description
    CytoPherx, Inc., founded in July 2007 and headquartered in Ann Arbor, Michigan, is a venture-backed, clinical stage medical device company addressing inflammation-based diseases and conditions with a proprietary selective cytopheresis system.

    The Company’s products are custom, patent-protected configurations of commercially available hollow fiber dialysis filters that are used in a proprietary manner to sequester and deactivate leukocytes in the patient’s blood system. The Company is initially focused on acute renal failure (ARF), end-stage renal disease (ESRD) and acute inflammation induced by cardio pulmonary bypass (CPB) surgery.

  • Website
    http://www.cytopherx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.